Announcement on Progress in Providing Guarantee for Subsidiary
Filed with SSE · · 12 pages · Chinese
Jointown Pharmaceutical Group Co., Ltd. on 6ix
Earlier from Jointown Pharmaceutical
- Announcement on Issuance of the Phase I Asset-backed Notes for 2026 and Related Party Transactions
- Announcement on Subsidiary Obtaining Approval for Marketing of Chemical APIs
- Announcement on Implementation of Dividend Distribution for 2025
- Announcement on Subsidiary's Drug Passing Generic Drug Consistency Evaluation
- Announcement on Resolutions of the 2025 Annual General Meeting
Later from Jointown Pharmaceutical
- Announcement on Release and Pledge of Shares by the Controlling Shareholder and Its Persons Acting in Concert
- Announcement on Resolutions of the 20th Meeting of the 6th Board of Directors
- Announcement on Attending the 2026 Collective Reception Day for Investors of Listed Companies in Hubei Jurisdiction
- Announcement on Entrusted Wealth Management of Temporarily Idle Funds for Q2 2026
- Announcement on Inclusion of Products of Subsidiaries in the "National Essential Medicines List (2026 Edition)"
Follow Jointown Pharmaceutical into a list and get an email when it puts out news.
Follow Jointown Pharmaceutical